Part 4: Osteoblast Suppression & Niche Stabilization \u2014 Guide<\/title>\r\n <meta name=\"viewport\" content=\"width=device-width, initial-scale=1\" \/>\r\n <meta name=\"description\" content=\"Part 4 of the series: how breast cancer cells suppress osteoblasts and stabilize a pro-tumor bone niche. Exact article text preserved; designed for patients and researchers.\" \/>\r\n <meta name=\"robots\" content=\"index, follow\" \/>\r\n <link rel=\"canonical\" href=\"https:\/\/www.example.com\/canonical-placeholder\" \/>\r\n\r\n \r\n <meta property=\"og:type\" content=\"article\" \/>\r\n <meta property=\"og:title\" content=\"Part 4: Osteoblast Suppression & Niche Stabilization \u2014 Guide\" \/>\r\n <meta property=\"og:description\" content=\"How DKK1\/SOST, SPP1, and CTGF weaken bone building and stabilize a pro-tumor niche. Exact text preserved.\" \/>\r\n <meta property=\"og:url\" content=\"https:\/\/www.example.com\/canonical-placeholder\" \/>\r\n <meta property=\"og:site_name\" content=\"Art of Healing Cancer\" \/>\r\n\r\n \r\n <meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n <meta name=\"twitter:title\" content=\"Part 4: Osteoblast Suppression & Niche Stabilization \u2014 Guide\" \/>\r\n <meta name=\"twitter:description\" content=\"Osteoblast suppression and niche remodeling in bone metastasis\u2014patient-friendly, research-ready.\" \/>\r\n\r\n \r\n <script type=\"application\/ld+json\">\r\n {\r\n \"@context\":\"https:\/\/schema.org\",\r\n \"@type\":\"Article\",\r\n \"headline\":\"Part 4: Osteoblast Suppression & Niche Stabilization \u2014 Guide\",\r\n \"description\":\"How breast cancer cells suppress osteoblasts (DKK1, SOST) and remodel the matrix (SPP1, CTGF) to stabilize a pro-tumor bone niche.\",\r\n \"inLanguage\":\"en\",\r\n \"datePublished\":\"2025-08-18\",\r\n \"dateModified\":\"2025-08-18\",\r\n \"author\":{\"@type\":\"Organization\",\"name\":\"Research Team Art of healing Cancer\"},\r\n \"publisher\":{\"@type\":\"Organization\",\"name\":\"Art of Healing Cancer\"},\r\n \"mainEntityOfPage\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.example.com\/canonical-placeholder\"},\r\n \"articleSection\":\"Oncology\"\r\n }\r\n <\/script>\r\n\r\n \r\n <script type=\"application\/ld+json\">\r\n {\r\n \"@context\":\"https:\/\/schema.org\",\r\n \"@type\":\"FAQPage\",\r\n \"mainEntity\":[\r\n {\r\n \"@type\":\"Question\",\r\n \"name\":\"Which signals suppress osteoblasts in bone metastasis?\",\r\n \"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Wnt antagonists DKK1 and SOST reduce osteoblast activity, tipping the balance toward bone resorption.\"}\r\n },\r\n {\r\n \"@type\":\"Question\",\r\n \"name\":\"How do tumor cells stabilize a pro-tumor bone niche?\",\r\n \"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Matrix and adhesion cues such as SPP1 (osteopontin) and CTGF promote firm attachment and protective remodeling of the local microenvironment.\"}\r\n }\r\n ]\r\n }\r\n <\/script>\r\n\r\n <style>\r\n \/* ===== Brand tokens (WCAG AA) \u2014 suffix 2743 ===== *\/\r\n :root{\r\n --navy-2743:#0D2B5A; --navy-dark-2743:#0B2240;\r\n --aqua-2743:#00B7C7; --aqua2-2743:#20C2CF;\r\n --white-2743:#FFFFFF; --gray-2743:#E9EEF4;\r\n --graphite-2743:#1F2A37; --muted-2743:#4B5563;\r\n --border-2743:#d7e0ea; --soft-2743:#F7FBFD;\r\n }\r\n html,body{margin:0;padding:0}\r\n body.page-2743{\r\n color:var(--graphite-2743); background:#ffffff;\r\n font-family:ui-sans-serif,system-ui,-apple-system,Segoe UI,Roboto,Helvetica,Arial,\"Apple Color Emoji\",\"Segoe UI Emoji\";\r\n font-size:17px; line-height:1.65; -webkit-font-smoothing:antialiased; text-rendering:optimizeLegibility;\r\n }\r\n .wrap-2743{max-width:1080px;margin:0 auto;padding:0 22px}\r\n\r\n \/* ===== Hero (angled band for visual change) ===== *\/\r\n .hero-2743{\r\n background:\r\n linear-gradient(160deg, var(--navy-2743) 0%, var(--navy-dark-2743) 60%),\r\n linear-gradient(180deg, var(--navy-2743), var(--navy-dark-2743));\r\n color:var(--white-2743);\r\n padding:56px 0 38px;\r\n position:relative;\r\n overflow:hidden;\r\n border-bottom:1px solid rgba(255,255,255,.12);\r\n box-shadow:0 12px 24px rgba(13,43,90,.18);\r\n }\r\n .hero-2743::after{\r\n content:\"\"; position:absolute; inset:auto -8% -50px -8%;\r\n height:140px; background:linear-gradient(90deg,var(--aqua-2743),var(--aqua2-2743));\r\n transform:skewY(-6deg); opacity:.16;\r\n }\r\n .h1-2743{margin:0 0 10px;font-size:clamp(28px,4.4vw,44px);line-height:1.18;font-weight:850;letter-spacing:.2px}\r\n .ribbon-2743{display:inline-block;padding:6px 12px;border-radius:999px;background:linear-gradient(90deg,var(--aqua-2743),var(--aqua2-2743));color:#fff;font-weight:800;font-size:12px;text-transform:uppercase;letter-spacing:.35px}\r\n .meta-2743{margin-top:14px;display:flex;flex-wrap:wrap;gap:10px 18px}\r\n .meta-2743 .item-2743{color:#dff7fb;font-weight:700;font-size:14px}\r\n .sub-2743{margin-top:14px;font-size:15px;color:#eef6fb}\r\n\r\n \/* ===== Article card (soft outline, rounded) ===== *\/\r\n .card-2743{background:#fff;border:1px solid var(--border-2743);border-radius:20px;box-shadow:0 1px 2px rgba(13,43,90,.06),0 10px 24px rgba(13,43,90,.08);overflow:hidden;margin:32px 0 72px}\r\n .head-2743{padding:18px 22px;background:linear-gradient(180deg,#f4f8fb 0%,#eef5fa 100%);border-bottom:1px solid var(--border-2743)}\r\n .note-2743{border-left:5px solid var(--aqua-2743);background:var(--soft-2743);padding:14px 16px;border-radius:10px;color:var(--muted-2743);font-size:14px}\r\n\r\n \/* ===== Section header ribbons ===== *\/\r\n .band-2743{\r\n margin:26px 0 12px; padding:0; position:relative;\r\n color:var(--navy-dark-2743); font-size:20px; font-weight:800;\r\n }\r\n .band-2743 span{\r\n display:inline-block; padding:12px 16px 12px 14px; border-radius:12px;\r\n background:linear-gradient(90deg, #f2f7fb, #eaf2f9);\r\n border:1px solid var(--border-2743);\r\n }\r\n .band-2743::before{\r\n content:\"\"; position:absolute; left:-6px; top:50%; transform:translateY(-50%);\r\n width:6px; height:28px; border-radius:4px;\r\n background:linear-gradient(180deg,var(--aqua-2743),var(--aqua2-2743));\r\n }\r\n\r\n \/* ===== Pill subheads ===== *\/\r\n .pill-2743{\r\n display:inline-block; margin:18px 0 10px; padding:8px 12px;\r\n background:var(--soft-2743); border:1px solid var(--border-2743); border-radius:999px;\r\n font-size:15px; font-weight:800; color:var(--navy-2743)\r\n }\r\n\r\n .content-2743{padding:26px 22px 32px}\r\n .p-2743{margin:0 0 14px}\r\n .ul-2743{margin:0 0 14px 22px}\r\n .ol-2743{margin:0 0 14px 22px}\r\n .ul-2743 li,.ol-2743 li{margin:6px 0}\r\n\r\n \/* ===== Split info cards (visual change vs previous parts) ===== *\/\r\n .grid-2743{display:grid;gap:16px;grid-template-columns:1fr}\r\n @media (min-width:780px){.grid-2743{grid-template-columns:1fr 1fr}}\r\n .cardInfo-2743{\r\n border:1px solid var(--border-2743); border-radius:16px;\r\n background:linear-gradient(180deg,#ffffff 0%,#f7fbfd 100%);\r\n box-shadow:0 6px 14px rgba(13,43,90,.06); overflow:hidden; position:relative;\r\n }\r\n .cardHead-2743{\r\n padding:12px 14px; color:#fff;\r\n background:\r\n linear-gradient(90deg, var(--aqua-2743), var(--aqua2-2743));\r\n display:flex; align-items:center; justify-content:space-between; gap:10px;\r\n }\r\n .cardTitle-2743{font-weight:900; letter-spacing:.2px}\r\n .tag-2743{font-size:12px; font-weight:800; opacity:.95}\r\n .cardBody-2743{padding:12px 14px}\r\n .cardBody-2743 ul{margin:8px 0 0 18px}\r\n .cardBody-2743 li{margin:6px 0}\r\n\r\n \/* ===== Timeline list for functional handoff ===== *\/\r\n .timeline-2743{position:relative; margin:6px 0 6px 0; padding-left:22px}\r\n .timeline-2743::before{\r\n content:\"\"; position:absolute; left:8px; top:0; bottom:0; width:2px;\r\n background:linear-gradient(180deg,var(--aqua-2743),var(--aqua2-2743));\r\n border-radius:2px; opacity:.7;\r\n }\r\n .step-2743{position:relative; margin:14px 0}\r\n .step-2743::before{\r\n content:\"\"; position:absolute; left:-6px; top:6px; width:10px; height:10px;\r\n border-radius:999px; background:var(--aqua-2743); box-shadow:0 0 0 3px #e6f9fb;\r\n }\r\n\r\n \/* ===== Summary chips ===== *\/\r\n .chips-2743{display:grid;gap:10px;margin-top:12px}\r\n .chip-2743{background:var(--soft-2743);border:1px solid var(--border-2743);padding:10px 12px;border-radius:12px;font-weight:700;color:var(--navy-2743)}\r\n\r\n \/* ===== Footer ===== *\/\r\n .foot-2743{margin-top:22px;font-size:13px;color:var(--muted-2743);border-top:1px dashed var(--border-2743);padding-top:14px}\r\n <\/style>\r\n<\/head>\r\n<body class=\"page-2743\">\r\n <header class=\"hero-2743\" role=\"banner\">\r\n <div class=\"wrap-2743\">\r\n <span class=\"ribbon-2743\">Oncology \u00b7 Series<\/span>\r\n <h1 class=\"h1-2743\">Part 4 \u2014 Osteoblast Suppression & Niche Stabilization<\/h1>\r\n <div class=\"meta-2743\" aria-label=\"Article metadata\">\r\n <div class=\"item-2743\">Author: <strong>Research Team Art of healing Cancer<\/strong><\/div>\r\n <div class=\"item-2743\">Credentials: <strong>Oncology research & editorial team<\/strong><\/div>\r\n <div class=\"item-2743\">Updated: <strong>August 18, 2025<\/strong><\/div>\r\n <div class=\"item-2743\">Estimated reading time: <strong>\u22486\u20137 min<\/strong><\/div>\r\n <\/div>\r\n <p class=\"sub-2743\">Designed for patients and researchers\u2014clean, scannable, and accessible.<\/p>\r\n <\/div>\r\n <\/header>\r\n\r\n <main>\r\n <div class=\"wrap-2743\">\r\n <article class=\"card-2743\" itemscope itemtype=\"https:\/\/schema.org\/Article\">\r\n <div class=\"head-2743\">\r\n <div class=\"note-2743\"><strong>Note:<\/strong> The article body below is included <em>exactly<\/em> as provided\u2014no deletions or edits\u2014only structured and styled for readability.<\/div>\r\n <\/div>\r\n\r\n <div class=\"content-2743\" itemprop=\"articleBody\">\r\n \r\n\r\n <h2 class=\"band-2743\"><span>4) Osteoblast Suppression and Niche Stabilization \u2014 In Simple Terms<\/span><\/h2>\r\n <p class=\"p-2743\">After cancer cells start the bone-destruction loop, they also work to keep the environment \u201ctuned\u201d in their favor. One big way they do this is by turning down the body\u2019s natural bone builders (osteoblasts) and reshaping the local scaffolding so it\u2019s easier for cancer to stick around and grow. This section explains the key players, what they do, and why it matters.<\/p>\r\n\r\n <h2 class=\"band-2743\"><span>The key players and what they do<\/span><\/h2>\r\n\r\n <div class=\"grid-2743\">\r\n \r\n <section class=\"cardInfo-2743\">\r\n <div class=\"cardHead-2743\">\r\n <div class=\"cardTitle-2743\">* DKK1 and SOST (Wnt antagonists; suppress osteoblasts)<\/div>\r\n <div class=\"tag-2743\">Wnt antagonists<\/div>\r\n <\/div>\r\n <div class=\"cardBody-2743\">\r\n <ul class=\"ul-2743\">\r\n <li>What they are:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>DKK1 and sclerostin (SOST) are natural brakes on the Wnt signaling pathway.<\/li>\r\n <li>Wnt signaling is essential for osteoblasts\u2014the cells that build new bone.<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>What they do:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>When DKK1 or SOST levels are high, Wnt signaling is blocked.<\/li>\r\n <li>Osteoblasts slow down or become less active, and bone formation drops.<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Why it matters:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Healthy bone relies on a balance: osteoclasts remove old bone, osteoblasts rebuild it. DKK1\/SOST tip the seesaw by weakening the builders, so breakdown outpaces repair. That leaves bone weaker and more hospitable to tumor cells.<\/li>\r\n <\/ul>\r\n <\/div>\r\n <\/section>\r\n\r\n \r\n <section class=\"cardInfo-2743\">\r\n <div class=\"cardHead-2743\">\r\n <div class=\"cardTitle-2743\">* SPP1 (osteopontin) and CTGF (connective tissue growth factor)<\/div>\r\n <div class=\"tag-2743\">Adhesion & matrix<\/div>\r\n <\/div>\r\n <div class=\"cardBody-2743\">\r\n <ul class=\"ul-2743\">\r\n <li>What they are:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>SPP1 (osteopontin) is a sticky matrix protein that helps cells attach to bone surfaces.<\/li>\r\n <li>CTGF is a signal that influences how the surrounding scaffolding (extracellular matrix) is laid down and remodeled.<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>What they do:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Osteopontin acts like Velcro\u2014helping cancer cells latch onto bone and marrow surfaces.<\/li>\r\n <li>CTGF helps re-shape the local matrix, creating a supportive \u201cnest\u201d around the tumor cells where nutrients, signals, and space are more favorable for their survival and growth.<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Why it matters:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Good attachment and a supportive matrix mean tumor cells are less likely to be washed away or attacked effectively, and more likely to persist and expand.<\/li>\r\n <\/ul>\r\n <\/div>\r\n <\/section>\r\n <\/div>\r\n\r\n <h2 class=\"band-2743\"><span>The functional handoff: how suppression and stabilization lock in the advantage<\/span><\/h2>\r\n\r\n <div class=\"timeline-2743\">\r\n <div class=\"step-2743\">\r\n <div class=\"pill-2743\">1. Reduced osteoblast activity tips the balance toward net bone resorption<\/div>\r\n <ul class=\"ul-2743\">\r\n <li>With DKK1 and SOST pressing down on Wnt signaling, osteoblasts build less bone.<\/li>\r\n <li>Meanwhile, osteoclasts (already revved up by earlier steps) keep dissolving bone.<\/li>\r\n <li>Net effect: Bone loses ground, growing progressively weaker in the areas where tumor cells sit.<\/li>\r\n <\/ul>\r\n <\/div>\r\n\r\n <div class=\"step-2743\">\r\n <div class=\"pill-2743\">2. Adhesion and matrix remodeling stabilize a pro-tumor bone niche<\/div>\r\n <ul class=\"ul-2743\">\r\n <li>Osteopontin (SPP1) gives cancer cells a strong grip on bone surfaces, making it easier to stay put and harder for the body to dislodge them.<\/li>\r\n <li>CTGF helps organize the surrounding matrix into a structure that shelters tumor cells, cushions them from stress, and may concentrate growth signals nearby.<\/li>\r\n <li>Net effect: The \u201csoil\u201d around the cancer becomes stable, customized, and self-maintaining.<\/li>\r\n <\/ul>\r\n <\/div>\r\n <\/div>\r\n\r\n <h2 class=\"band-2743\"><span>Why this step is so important<\/span><\/h2>\r\n <ul class=\"ul-2743\">\r\n <li>It locks in the vicious cycle:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>If osteoblasts can\u2019t rebuild, each episode of bone breakdown leaves a bigger deficit.<\/li>\r\n <li>The environment stays skewed toward resorption, which continues to release growth factors from bone and feed the tumor.<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>It helps tumor cells persist:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Stronger adhesion and a remodeled matrix make it physically and biologically harder to clear cancer cells.<\/li>\r\n <li>Tumor cells gain a sheltered microenvironment that supports low-oxygen survival, immune evasion, and steady growth.<\/li>\r\n <\/ul>\r\n\r\n <h2 class=\"band-2743\"><span>A simple story of what happens<\/span><\/h2>\r\n <ul class=\"ul-2743\">\r\n <li>First, cancer cells kick osteoclasts into high gear, so bone gets chewed up.<\/li>\r\n <li>Then, they press the brakes on the builders using DKK1 and SOST so the bone can\u2019t repair itself properly.<\/li>\r\n <li>At the same time, they lay down a sticky, remodeled scaffold (with osteopontin and CTGF) that helps them cling to bone and shape a safe niche.<\/li>\r\n <li>Over time, this creates fragile, tumor-friendly zones where cancer can linger and expand.<\/li>\r\n <\/ul>\r\n\r\n <h2 class=\"band-2743\"><span>Where this process can be interrupted (conceptually)<\/span><\/h2>\r\n <ul class=\"ul-2743\">\r\n <li>Lift the brakes on osteoblasts:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Strategies that reduce DKK1 or SOST activity could restore Wnt signaling, encouraging osteoblasts to rebuild bone and rebalance the system.<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Reduce the \u201cVelcro\u201d and remodeling:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Lowering osteopontin levels or interfering with CTGF-driven matrix changes could make it harder for tumor cells to attach and maintain their protective niche.<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Combine with osteoclast control:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Supporting osteoblasts while also calming osteoclasts addresses both sides of the seesaw\u2014rebuilding bone while slowing its destruction.<\/li>\r\n <\/ul>\r\n\r\n <h2 class=\"band-2743\"><span>In short<\/span><\/h2>\r\n <div class=\"chips-2743\">\r\n <div class=\"chip-2743\">DKK1 and SOST act like brakes on the bone-building pathway (Wnt), weakening the bone\u2019s ability to repair itself.<\/div>\r\n <div class=\"chip-2743\">SPP1 (osteopontin) and CTGF help cancer cells stick to bone and reshape their surroundings into a protective nest.<\/div>\r\n <div class=\"chip-2743\">Together, these changes keep the local environment tilted toward bone loss and tumor comfort\u2014stabilizing a niche that helps cancer persist and grow.<\/div>\r\n <\/div>\r\n\r\n <div class=\"foot-2743\">\u00a9 2025 Art of Healing Cancer \u00b7 Educational content only; not medical advice.<\/div>\r\n <\/div>\r\n <\/article>\r\n <\/div>\r\n <\/main>\r\n<\/body>\r\n<\/html>\r\n","protected":false},"excerpt":{"rendered":"Part 4: Osteoblast Suppression & Niche Stabilization \u2014 Guide Oncology \u00b7 Series Part 4 \u2014 Osteoblast Suppression & Niche Stabilization Author: Research Team Art of healing Cancer Credentials: Oncology research & editorial team Updated: August 18, 2025 Estimated reading time: \u22486\u20137 min Designed for patients and researchers\u2014clean, scannable, and accessible. Note: The article body below … <a title=\"Part 4: Osteoblast Suppression & Niche Stabilization \u2014 Guide\" class=\"read-more\" href=\"https:\/\/artofhealingcancer.com\/blogs\/part-4-osteoblast-suppression-niche-stabilization-guide\/\" aria-label=\"Read more about Part 4: Osteoblast Suppression & Niche Stabilization \u2014 Guide\">Read more<\/a>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,21],"tags":[204,214,113,205,174,112,211,208,202,209,210,199,171,215,198,190,206,195,136,213,191,203,207,217,218,212,201,216,200],"class_list":["post-462","post","type-post","status-publish","format-standard","hentry","category-breast-cancer","category-stage-4-cancer","tag-bone-formation","tag-bone-fragility","tag-bone-marrow-niche","tag-bone-remodeling","tag-bone-resorption","tag-breast-cancer-bone-metastasis","tag-cell-matrix-adhesion","tag-ctgf-connective-tissue-growth-factor","tag-dkk1","tag-extracellular-matrix-ecm","tag-matrix-remodeling","tag-niche-stabilization","tag-oncology-research","tag-osteoblast-differentiation","tag-osteoblast-suppression","tag-osteoblasts","tag-osteoclast-osteoblast-imbalance","tag-osteolysis","tag-patient-education","tag-pro-tumor-microenvironment","tag-skeletal-related-events","tag-sost-sclerostin","tag-spp1-osteopontin","tag-stromal-remodeling","tag-supportive-tumor-niche","tag-tumor-adhesion","tag-wnt-antagonists","tag-wnt-pathway-blockade","tag-wnt-signaling"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/posts\/462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/comments?post=462"}],"version-history":[{"count":1,"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/posts\/462\/revisions"}],"predecessor-version":[{"id":463,"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/posts\/462\/revisions\/463"}],"wp:attachment":[{"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/media?parent=462"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/categories?post=462"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/tags?post=462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

{"id":462,"date":"2025-08-18T23:58:28","date_gmt":"2025-08-18T18:28:28","guid":{"rendered":"https:\/\/artofhealingcancer.com\/blogs\/?p=462"},"modified":"2025-08-18T23:58:28","modified_gmt":"2025-08-18T18:28:28","slug":"part-4-osteoblast-suppression-niche-stabilization-guide","status":"publish","type":"post","link":"https:\/\/artofhealingcancer.com\/blogs\/part-4-osteoblast-suppression-niche-stabilization-guide\/","title":{"rendered":"Part 4: Osteoblast Suppression & Niche Stabilization \u2014 Guide"},"content":{"rendered":"\r\n\r\n\r\n \r\n Part 4: Osteoblast Suppression & Niche Stabilization \u2014 Guide<\/title>\r\n <meta name=\"viewport\" content=\"width=device-width, initial-scale=1\" \/>\r\n <meta name=\"description\" content=\"Part 4 of the series: how breast cancer cells suppress osteoblasts and stabilize a pro-tumor bone niche. Exact article text preserved; designed for patients and researchers.\" \/>\r\n <meta name=\"robots\" content=\"index, follow\" \/>\r\n <link rel=\"canonical\" href=\"https:\/\/www.example.com\/canonical-placeholder\" \/>\r\n\r\n \r\n <meta property=\"og:type\" content=\"article\" \/>\r\n <meta property=\"og:title\" content=\"Part 4: Osteoblast Suppression & Niche Stabilization \u2014 Guide\" \/>\r\n <meta property=\"og:description\" content=\"How DKK1\/SOST, SPP1, and CTGF weaken bone building and stabilize a pro-tumor niche. Exact text preserved.\" \/>\r\n <meta property=\"og:url\" content=\"https:\/\/www.example.com\/canonical-placeholder\" \/>\r\n <meta property=\"og:site_name\" content=\"Art of Healing Cancer\" \/>\r\n\r\n \r\n <meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n <meta name=\"twitter:title\" content=\"Part 4: Osteoblast Suppression & Niche Stabilization \u2014 Guide\" \/>\r\n <meta name=\"twitter:description\" content=\"Osteoblast suppression and niche remodeling in bone metastasis\u2014patient-friendly, research-ready.\" \/>\r\n\r\n \r\n <script type=\"application\/ld+json\">\r\n {\r\n \"@context\":\"https:\/\/schema.org\",\r\n \"@type\":\"Article\",\r\n \"headline\":\"Part 4: Osteoblast Suppression & Niche Stabilization \u2014 Guide\",\r\n \"description\":\"How breast cancer cells suppress osteoblasts (DKK1, SOST) and remodel the matrix (SPP1, CTGF) to stabilize a pro-tumor bone niche.\",\r\n \"inLanguage\":\"en\",\r\n \"datePublished\":\"2025-08-18\",\r\n \"dateModified\":\"2025-08-18\",\r\n \"author\":{\"@type\":\"Organization\",\"name\":\"Research Team Art of healing Cancer\"},\r\n \"publisher\":{\"@type\":\"Organization\",\"name\":\"Art of Healing Cancer\"},\r\n \"mainEntityOfPage\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.example.com\/canonical-placeholder\"},\r\n \"articleSection\":\"Oncology\"\r\n }\r\n <\/script>\r\n\r\n \r\n <script type=\"application\/ld+json\">\r\n {\r\n \"@context\":\"https:\/\/schema.org\",\r\n \"@type\":\"FAQPage\",\r\n \"mainEntity\":[\r\n {\r\n \"@type\":\"Question\",\r\n \"name\":\"Which signals suppress osteoblasts in bone metastasis?\",\r\n \"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Wnt antagonists DKK1 and SOST reduce osteoblast activity, tipping the balance toward bone resorption.\"}\r\n },\r\n {\r\n \"@type\":\"Question\",\r\n \"name\":\"How do tumor cells stabilize a pro-tumor bone niche?\",\r\n \"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Matrix and adhesion cues such as SPP1 (osteopontin) and CTGF promote firm attachment and protective remodeling of the local microenvironment.\"}\r\n }\r\n ]\r\n }\r\n <\/script>\r\n\r\n <style>\r\n \/* ===== Brand tokens (WCAG AA) \u2014 suffix 2743 ===== *\/\r\n :root{\r\n --navy-2743:#0D2B5A; --navy-dark-2743:#0B2240;\r\n --aqua-2743:#00B7C7; --aqua2-2743:#20C2CF;\r\n --white-2743:#FFFFFF; --gray-2743:#E9EEF4;\r\n --graphite-2743:#1F2A37; --muted-2743:#4B5563;\r\n --border-2743:#d7e0ea; --soft-2743:#F7FBFD;\r\n }\r\n html,body{margin:0;padding:0}\r\n body.page-2743{\r\n color:var(--graphite-2743); background:#ffffff;\r\n font-family:ui-sans-serif,system-ui,-apple-system,Segoe UI,Roboto,Helvetica,Arial,\"Apple Color Emoji\",\"Segoe UI Emoji\";\r\n font-size:17px; line-height:1.65; -webkit-font-smoothing:antialiased; text-rendering:optimizeLegibility;\r\n }\r\n .wrap-2743{max-width:1080px;margin:0 auto;padding:0 22px}\r\n\r\n \/* ===== Hero (angled band for visual change) ===== *\/\r\n .hero-2743{\r\n background:\r\n linear-gradient(160deg, var(--navy-2743) 0%, var(--navy-dark-2743) 60%),\r\n linear-gradient(180deg, var(--navy-2743), var(--navy-dark-2743));\r\n color:var(--white-2743);\r\n padding:56px 0 38px;\r\n position:relative;\r\n overflow:hidden;\r\n border-bottom:1px solid rgba(255,255,255,.12);\r\n box-shadow:0 12px 24px rgba(13,43,90,.18);\r\n }\r\n .hero-2743::after{\r\n content:\"\"; position:absolute; inset:auto -8% -50px -8%;\r\n height:140px; background:linear-gradient(90deg,var(--aqua-2743),var(--aqua2-2743));\r\n transform:skewY(-6deg); opacity:.16;\r\n }\r\n .h1-2743{margin:0 0 10px;font-size:clamp(28px,4.4vw,44px);line-height:1.18;font-weight:850;letter-spacing:.2px}\r\n .ribbon-2743{display:inline-block;padding:6px 12px;border-radius:999px;background:linear-gradient(90deg,var(--aqua-2743),var(--aqua2-2743));color:#fff;font-weight:800;font-size:12px;text-transform:uppercase;letter-spacing:.35px}\r\n .meta-2743{margin-top:14px;display:flex;flex-wrap:wrap;gap:10px 18px}\r\n .meta-2743 .item-2743{color:#dff7fb;font-weight:700;font-size:14px}\r\n .sub-2743{margin-top:14px;font-size:15px;color:#eef6fb}\r\n\r\n \/* ===== Article card (soft outline, rounded) ===== *\/\r\n .card-2743{background:#fff;border:1px solid var(--border-2743);border-radius:20px;box-shadow:0 1px 2px rgba(13,43,90,.06),0 10px 24px rgba(13,43,90,.08);overflow:hidden;margin:32px 0 72px}\r\n .head-2743{padding:18px 22px;background:linear-gradient(180deg,#f4f8fb 0%,#eef5fa 100%);border-bottom:1px solid var(--border-2743)}\r\n .note-2743{border-left:5px solid var(--aqua-2743);background:var(--soft-2743);padding:14px 16px;border-radius:10px;color:var(--muted-2743);font-size:14px}\r\n\r\n \/* ===== Section header ribbons ===== *\/\r\n .band-2743{\r\n margin:26px 0 12px; padding:0; position:relative;\r\n color:var(--navy-dark-2743); font-size:20px; font-weight:800;\r\n }\r\n .band-2743 span{\r\n display:inline-block; padding:12px 16px 12px 14px; border-radius:12px;\r\n background:linear-gradient(90deg, #f2f7fb, #eaf2f9);\r\n border:1px solid var(--border-2743);\r\n }\r\n .band-2743::before{\r\n content:\"\"; position:absolute; left:-6px; top:50%; transform:translateY(-50%);\r\n width:6px; height:28px; border-radius:4px;\r\n background:linear-gradient(180deg,var(--aqua-2743),var(--aqua2-2743));\r\n }\r\n\r\n \/* ===== Pill subheads ===== *\/\r\n .pill-2743{\r\n display:inline-block; margin:18px 0 10px; padding:8px 12px;\r\n background:var(--soft-2743); border:1px solid var(--border-2743); border-radius:999px;\r\n font-size:15px; font-weight:800; color:var(--navy-2743)\r\n }\r\n\r\n .content-2743{padding:26px 22px 32px}\r\n .p-2743{margin:0 0 14px}\r\n .ul-2743{margin:0 0 14px 22px}\r\n .ol-2743{margin:0 0 14px 22px}\r\n .ul-2743 li,.ol-2743 li{margin:6px 0}\r\n\r\n \/* ===== Split info cards (visual change vs previous parts) ===== *\/\r\n .grid-2743{display:grid;gap:16px;grid-template-columns:1fr}\r\n @media (min-width:780px){.grid-2743{grid-template-columns:1fr 1fr}}\r\n .cardInfo-2743{\r\n border:1px solid var(--border-2743); border-radius:16px;\r\n background:linear-gradient(180deg,#ffffff 0%,#f7fbfd 100%);\r\n box-shadow:0 6px 14px rgba(13,43,90,.06); overflow:hidden; position:relative;\r\n }\r\n .cardHead-2743{\r\n padding:12px 14px; color:#fff;\r\n background:\r\n linear-gradient(90deg, var(--aqua-2743), var(--aqua2-2743));\r\n display:flex; align-items:center; justify-content:space-between; gap:10px;\r\n }\r\n .cardTitle-2743{font-weight:900; letter-spacing:.2px}\r\n .tag-2743{font-size:12px; font-weight:800; opacity:.95}\r\n .cardBody-2743{padding:12px 14px}\r\n .cardBody-2743 ul{margin:8px 0 0 18px}\r\n .cardBody-2743 li{margin:6px 0}\r\n\r\n \/* ===== Timeline list for functional handoff ===== *\/\r\n .timeline-2743{position:relative; margin:6px 0 6px 0; padding-left:22px}\r\n .timeline-2743::before{\r\n content:\"\"; position:absolute; left:8px; top:0; bottom:0; width:2px;\r\n background:linear-gradient(180deg,var(--aqua-2743),var(--aqua2-2743));\r\n border-radius:2px; opacity:.7;\r\n }\r\n .step-2743{position:relative; margin:14px 0}\r\n .step-2743::before{\r\n content:\"\"; position:absolute; left:-6px; top:6px; width:10px; height:10px;\r\n border-radius:999px; background:var(--aqua-2743); box-shadow:0 0 0 3px #e6f9fb;\r\n }\r\n\r\n \/* ===== Summary chips ===== *\/\r\n .chips-2743{display:grid;gap:10px;margin-top:12px}\r\n .chip-2743{background:var(--soft-2743);border:1px solid var(--border-2743);padding:10px 12px;border-radius:12px;font-weight:700;color:var(--navy-2743)}\r\n\r\n \/* ===== Footer ===== *\/\r\n .foot-2743{margin-top:22px;font-size:13px;color:var(--muted-2743);border-top:1px dashed var(--border-2743);padding-top:14px}\r\n <\/style>\r\n<\/head>\r\n<body class=\"page-2743\">\r\n <header class=\"hero-2743\" role=\"banner\">\r\n <div class=\"wrap-2743\">\r\n <span class=\"ribbon-2743\">Oncology \u00b7 Series<\/span>\r\n <h1 class=\"h1-2743\">Part 4 \u2014 Osteoblast Suppression & Niche Stabilization<\/h1>\r\n <div class=\"meta-2743\" aria-label=\"Article metadata\">\r\n <div class=\"item-2743\">Author: <strong>Research Team Art of healing Cancer<\/strong><\/div>\r\n <div class=\"item-2743\">Credentials: <strong>Oncology research & editorial team<\/strong><\/div>\r\n <div class=\"item-2743\">Updated: <strong>August 18, 2025<\/strong><\/div>\r\n <div class=\"item-2743\">Estimated reading time: <strong>\u22486\u20137 min<\/strong><\/div>\r\n <\/div>\r\n <p class=\"sub-2743\">Designed for patients and researchers\u2014clean, scannable, and accessible.<\/p>\r\n <\/div>\r\n <\/header>\r\n\r\n <main>\r\n <div class=\"wrap-2743\">\r\n <article class=\"card-2743\" itemscope itemtype=\"https:\/\/schema.org\/Article\">\r\n <div class=\"head-2743\">\r\n <div class=\"note-2743\"><strong>Note:<\/strong> The article body below is included <em>exactly<\/em> as provided\u2014no deletions or edits\u2014only structured and styled for readability.<\/div>\r\n <\/div>\r\n\r\n <div class=\"content-2743\" itemprop=\"articleBody\">\r\n \r\n\r\n <h2 class=\"band-2743\"><span>4) Osteoblast Suppression and Niche Stabilization \u2014 In Simple Terms<\/span><\/h2>\r\n <p class=\"p-2743\">After cancer cells start the bone-destruction loop, they also work to keep the environment \u201ctuned\u201d in their favor. One big way they do this is by turning down the body\u2019s natural bone builders (osteoblasts) and reshaping the local scaffolding so it\u2019s easier for cancer to stick around and grow. This section explains the key players, what they do, and why it matters.<\/p>\r\n\r\n <h2 class=\"band-2743\"><span>The key players and what they do<\/span><\/h2>\r\n\r\n <div class=\"grid-2743\">\r\n \r\n <section class=\"cardInfo-2743\">\r\n <div class=\"cardHead-2743\">\r\n <div class=\"cardTitle-2743\">* DKK1 and SOST (Wnt antagonists; suppress osteoblasts)<\/div>\r\n <div class=\"tag-2743\">Wnt antagonists<\/div>\r\n <\/div>\r\n <div class=\"cardBody-2743\">\r\n <ul class=\"ul-2743\">\r\n <li>What they are:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>DKK1 and sclerostin (SOST) are natural brakes on the Wnt signaling pathway.<\/li>\r\n <li>Wnt signaling is essential for osteoblasts\u2014the cells that build new bone.<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>What they do:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>When DKK1 or SOST levels are high, Wnt signaling is blocked.<\/li>\r\n <li>Osteoblasts slow down or become less active, and bone formation drops.<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Why it matters:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Healthy bone relies on a balance: osteoclasts remove old bone, osteoblasts rebuild it. DKK1\/SOST tip the seesaw by weakening the builders, so breakdown outpaces repair. That leaves bone weaker and more hospitable to tumor cells.<\/li>\r\n <\/ul>\r\n <\/div>\r\n <\/section>\r\n\r\n \r\n <section class=\"cardInfo-2743\">\r\n <div class=\"cardHead-2743\">\r\n <div class=\"cardTitle-2743\">* SPP1 (osteopontin) and CTGF (connective tissue growth factor)<\/div>\r\n <div class=\"tag-2743\">Adhesion & matrix<\/div>\r\n <\/div>\r\n <div class=\"cardBody-2743\">\r\n <ul class=\"ul-2743\">\r\n <li>What they are:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>SPP1 (osteopontin) is a sticky matrix protein that helps cells attach to bone surfaces.<\/li>\r\n <li>CTGF is a signal that influences how the surrounding scaffolding (extracellular matrix) is laid down and remodeled.<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>What they do:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Osteopontin acts like Velcro\u2014helping cancer cells latch onto bone and marrow surfaces.<\/li>\r\n <li>CTGF helps re-shape the local matrix, creating a supportive \u201cnest\u201d around the tumor cells where nutrients, signals, and space are more favorable for their survival and growth.<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Why it matters:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Good attachment and a supportive matrix mean tumor cells are less likely to be washed away or attacked effectively, and more likely to persist and expand.<\/li>\r\n <\/ul>\r\n <\/div>\r\n <\/section>\r\n <\/div>\r\n\r\n <h2 class=\"band-2743\"><span>The functional handoff: how suppression and stabilization lock in the advantage<\/span><\/h2>\r\n\r\n <div class=\"timeline-2743\">\r\n <div class=\"step-2743\">\r\n <div class=\"pill-2743\">1. Reduced osteoblast activity tips the balance toward net bone resorption<\/div>\r\n <ul class=\"ul-2743\">\r\n <li>With DKK1 and SOST pressing down on Wnt signaling, osteoblasts build less bone.<\/li>\r\n <li>Meanwhile, osteoclasts (already revved up by earlier steps) keep dissolving bone.<\/li>\r\n <li>Net effect: Bone loses ground, growing progressively weaker in the areas where tumor cells sit.<\/li>\r\n <\/ul>\r\n <\/div>\r\n\r\n <div class=\"step-2743\">\r\n <div class=\"pill-2743\">2. Adhesion and matrix remodeling stabilize a pro-tumor bone niche<\/div>\r\n <ul class=\"ul-2743\">\r\n <li>Osteopontin (SPP1) gives cancer cells a strong grip on bone surfaces, making it easier to stay put and harder for the body to dislodge them.<\/li>\r\n <li>CTGF helps organize the surrounding matrix into a structure that shelters tumor cells, cushions them from stress, and may concentrate growth signals nearby.<\/li>\r\n <li>Net effect: The \u201csoil\u201d around the cancer becomes stable, customized, and self-maintaining.<\/li>\r\n <\/ul>\r\n <\/div>\r\n <\/div>\r\n\r\n <h2 class=\"band-2743\"><span>Why this step is so important<\/span><\/h2>\r\n <ul class=\"ul-2743\">\r\n <li>It locks in the vicious cycle:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>If osteoblasts can\u2019t rebuild, each episode of bone breakdown leaves a bigger deficit.<\/li>\r\n <li>The environment stays skewed toward resorption, which continues to release growth factors from bone and feed the tumor.<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>It helps tumor cells persist:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Stronger adhesion and a remodeled matrix make it physically and biologically harder to clear cancer cells.<\/li>\r\n <li>Tumor cells gain a sheltered microenvironment that supports low-oxygen survival, immune evasion, and steady growth.<\/li>\r\n <\/ul>\r\n\r\n <h2 class=\"band-2743\"><span>A simple story of what happens<\/span><\/h2>\r\n <ul class=\"ul-2743\">\r\n <li>First, cancer cells kick osteoclasts into high gear, so bone gets chewed up.<\/li>\r\n <li>Then, they press the brakes on the builders using DKK1 and SOST so the bone can\u2019t repair itself properly.<\/li>\r\n <li>At the same time, they lay down a sticky, remodeled scaffold (with osteopontin and CTGF) that helps them cling to bone and shape a safe niche.<\/li>\r\n <li>Over time, this creates fragile, tumor-friendly zones where cancer can linger and expand.<\/li>\r\n <\/ul>\r\n\r\n <h2 class=\"band-2743\"><span>Where this process can be interrupted (conceptually)<\/span><\/h2>\r\n <ul class=\"ul-2743\">\r\n <li>Lift the brakes on osteoblasts:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Strategies that reduce DKK1 or SOST activity could restore Wnt signaling, encouraging osteoblasts to rebuild bone and rebalance the system.<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Reduce the \u201cVelcro\u201d and remodeling:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Lowering osteopontin levels or interfering with CTGF-driven matrix changes could make it harder for tumor cells to attach and maintain their protective niche.<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Combine with osteoclast control:<\/li>\r\n <\/ul>\r\n <ul class=\"ul-2743\">\r\n <li>Supporting osteoblasts while also calming osteoclasts addresses both sides of the seesaw\u2014rebuilding bone while slowing its destruction.<\/li>\r\n <\/ul>\r\n\r\n <h2 class=\"band-2743\"><span>In short<\/span><\/h2>\r\n <div class=\"chips-2743\">\r\n <div class=\"chip-2743\">DKK1 and SOST act like brakes on the bone-building pathway (Wnt), weakening the bone\u2019s ability to repair itself.<\/div>\r\n <div class=\"chip-2743\">SPP1 (osteopontin) and CTGF help cancer cells stick to bone and reshape their surroundings into a protective nest.<\/div>\r\n <div class=\"chip-2743\">Together, these changes keep the local environment tilted toward bone loss and tumor comfort\u2014stabilizing a niche that helps cancer persist and grow.<\/div>\r\n <\/div>\r\n\r\n <div class=\"foot-2743\">\u00a9 2025 Art of Healing Cancer \u00b7 Educational content only; not medical advice.<\/div>\r\n <\/div>\r\n <\/article>\r\n <\/div>\r\n <\/main>\r\n<\/body>\r\n<\/html>\r\n","protected":false},"excerpt":{"rendered":"Part 4: Osteoblast Suppression & Niche Stabilization \u2014 Guide Oncology \u00b7 Series Part 4 \u2014 Osteoblast Suppression & Niche Stabilization Author: Research Team Art of healing Cancer Credentials: Oncology research & editorial team Updated: August 18, 2025 Estimated reading time: \u22486\u20137 min Designed for patients and researchers\u2014clean, scannable, and accessible. Note: The article body below … <a title=\"Part 4: Osteoblast Suppression & Niche Stabilization \u2014 Guide\" class=\"read-more\" href=\"https:\/\/artofhealingcancer.com\/blogs\/part-4-osteoblast-suppression-niche-stabilization-guide\/\" aria-label=\"Read more about Part 4: Osteoblast Suppression & Niche Stabilization \u2014 Guide\">Read more<\/a>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,21],"tags":[204,214,113,205,174,112,211,208,202,209,210,199,171,215,198,190,206,195,136,213,191,203,207,217,218,212,201,216,200],"class_list":["post-462","post","type-post","status-publish","format-standard","hentry","category-breast-cancer","category-stage-4-cancer","tag-bone-formation","tag-bone-fragility","tag-bone-marrow-niche","tag-bone-remodeling","tag-bone-resorption","tag-breast-cancer-bone-metastasis","tag-cell-matrix-adhesion","tag-ctgf-connective-tissue-growth-factor","tag-dkk1","tag-extracellular-matrix-ecm","tag-matrix-remodeling","tag-niche-stabilization","tag-oncology-research","tag-osteoblast-differentiation","tag-osteoblast-suppression","tag-osteoblasts","tag-osteoclast-osteoblast-imbalance","tag-osteolysis","tag-patient-education","tag-pro-tumor-microenvironment","tag-skeletal-related-events","tag-sost-sclerostin","tag-spp1-osteopontin","tag-stromal-remodeling","tag-supportive-tumor-niche","tag-tumor-adhesion","tag-wnt-antagonists","tag-wnt-pathway-blockade","tag-wnt-signaling"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/posts\/462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/comments?post=462"}],"version-history":[{"count":1,"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/posts\/462\/revisions"}],"predecessor-version":[{"id":463,"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/posts\/462\/revisions\/463"}],"wp:attachment":[{"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/media?parent=462"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/categories?post=462"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/artofhealingcancer.com\/blogs\/wp-json\/wp\/v2\/tags?post=462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}